The aim of this programme is to improve your knowledge surrounding the measurement, clinical application and interpretation of measurable residual disease (MRD) in multiple myeloma.
Through completing this activity, participants will be able to:
All content has been developed with the US experience in mind, but the learning programme will be informative for healthcare professionals from any country.
MRD CONTENT ON VJHEMONC.COM IS SPONSORED BY ABBVIE LTD, ADAPTIVE BIOTECHNOLOGIES AND JANSSEN PHARMACEUTICALS (A JOHNSON & JOHNSON COMPANY). THE COMPANIES HAVE NO INFLUENCE OVER THE PRODUCTION OF THE CONTENT.
RETURN TO THE MRD HUB
By choosing to continue, you are confirming that you are a healthcare professional
Please enter your details if you would like to receive the latest hemonc news and updates